ARKG is trading at $44.42 (+3.21%) as weaker July employment data boosts expectations for easier Federal Reserve policy.
- Healthcare stocks are attracting rotation; falling Treasury yields and a softer dollar support rate-sensitive growth and biotechnology shares, while the Nasdaq is modestly lower.
- Recent drugmaker strength, including resilient GLP-1 demand, reinforces healthcare-sector momentum.
- August 10 trading is cautious ahead of the August 12 CPI report.